Preoperative Chemoradiation Therapy Decreases the Number of Lymph Nodes Resected During Esophagectomy

Male Neoplasm, Residual Esophageal Neoplasms Chemoradiotherapy, Adjuvant Adenocarcinoma Length of Stay Middle Aged Neoadjuvant Therapy 3. Good health Esophagectomy Survival Rate 03 medical and health sciences 0302 clinical medicine Antineoplastic Combined Chemotherapy Protocols Carcinoma, Squamous Cell Humans Lymph Node Excision Female Dose Fractionation, Radiation Lymph Nodes Cisplatin Retrospective Studies Tegafur
DOI: 10.1007/s00268-014-2847-x Publication Date: 2014-10-24T20:02:21Z
ABSTRACT
AbstractBackgroundThis study aimed to analyze the effect of preoperative chemoradiation on the adequacy of lymph node dissection.MethodsPatients with esophageal cancer treated with esophagectomy by the same surgeon between 2004 and 2011 were reviewed. Specimens were examined by the same pathologist. Patients were grouped into two depending on the type of treatment received.ResultsForty‐seven patients with curative esophagectomy were included in the study. Twenty patients had preoperative chemoradiation followed by surgery and 27 had surgery alone. Open and hybrid esophagectomy approaches were used. The average number of lymph nodes dissected was 16 ± 10 (1–39). There was a significant decrease in the number of lymph nodes examined in patients with preoperative chemoradiotherapy in comparison to surgery alone (p = 0.001). Median length of stay was 12 days. R0 resection rate was 96 %. The median survival was 36.3 months, with a 42 % 5‐year survival. Seven patients (25 %) had complete pathologic response following chemoradiation. No significant difference was recorded in terms of disease recurrence (p = 0.3). While morbidity was higher in the preoperative therapy group with 30 day mortality of 10 %, type of surgical approach does not seem to influence the number of lymph nodes dissected (p = 0.7).ConclusionsPreoperative chemoradiation decreases the number of harvested lymph nodes following esophagectomy regardless of the surgical technique used. The optimum number of lymph nodes currently recommended to be dissected for accurate nodal staging and survival needs revision in this group of patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (24)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....